1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | September 2025 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 792.76K | - |
| Net profit | -4.84M | - |
| EBITDA | 9.27M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €7.28M |
Number of shares | 6.69M |
52-week high/low | €16.66 - €0.93 |
| Dividends | No |
Beta | 1.47 |
P/E ratio | -0.53 |
PEG ratio | -0.01 |
P/B ratio | 0.48 |
P/S ratio | 0.00 |
Company profile
| Name | Sonnet BioTherapeutics Holdings Inc Ordinary Shares |
| CEO | Raghu Rao |
| Employees | 13 |
Discover assets
Shareholders of Sonnet BioTherapeutics Holdings Inc Ordinary Shares also invest in the following assets
